Lv1
40 积分 2024-07-01 加入
A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome
11天前
已完结
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
16天前
已完结
Differential roles of individual bile acid in physiology and disease
18天前
已完结
Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases
18天前
已完结
Structural characterisation of Cistanche tubulosa polysaccharides and their effects against non-alcoholic steatohepatitis via gut microbiota regulation
1个月前
已完结
Multi-omics analysis identifies a microbiota–bile acid–TLR signaling axis driving bladder injury in interstitial cystitis
2个月前
已完结
LDL-C–Related Cardiovascular Burden in China 2010 to 2030
2个月前
已完结
Probiotics for the treatment of hyperlipidemia: Focus on gut-liver axis and lipid metabolism
2个月前
已完结
Association of GLP-1 secretion with anti-hyperlipidemic effect of ginsenosides in high-fat diet fed rats
2个月前
已完结
Curcumae rhizoma and its major constituents against hepatobiliary disease: Pharmacotherapeutic properties and potential clinical applications
3个月前
已完结
皖公网安备34019202002308
